Difference between revisions of "M200"
Jump to navigation
Jump to search
(und) |
DavidB4-bot (talk | contribs) (→top: Spelling, grammar, and general fixes) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | M200 is a monoclonal [[antibody]] that is being studied in the treatment of some types of [[cancer]]. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors. | + | '''M200''' is a monoclonal [[antibody]] that is being studied in the treatment of some types of [[cancer]]. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors. |
M200 is also called volociximab. | M200 is also called volociximab. | ||
| − | [[ | + | [[Category:Medicine]] |
Latest revision as of 14:13, June 24, 2016
M200 is a monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors.
M200 is also called volociximab.